Theralase Technologies Inc. V.TLT

Updated May 1 2023

[Oden6570]

5 Canadian Trial sites ! Now 12 in total ! Has the trial locations increased or is this old info ?

Locations

United States, Illinois
Site 02-012 - University of Chicago	Recruiting
Chicago, Illinois, United States, 60637
Contact: Megan Mendez    773-702-1835    [e-mail]
Principal Investigator: Piyush Agarwal, MD
United States, Pennsylvania
Site 02-008 - MidLantic Urology	Recruiting
Bala-Cynwyd, Pennsylvania, United States, 19087
Contact: Cheryl Zinar    610-632-4137    [e-mail]
Principal Investigator: Laurence Belkoff, MD
United States, South Carolina
Site 02-006 - Carolina Urologic Research Center	Recruiting
Myrtle Beach, South Carolina, United States, 29572
Contact: Jennifer Sutton    843-449-1010 ext 316    [e-mail]
Principal Investigator: Dr. Neal Shore, MD
United States, Tennessee
Site 02-007 - Urology Associates, P. C	Recruiting
Nashville, Tennessee, United States, 37209
Contact: Micki Porcello    615-250-9282    [e-mail]
Principal Investigator: Dr. Gautam Jayram
United States, Texas
Site 02-010 - Urology San Antonio P. A	Recruiting
San Antonio, Texas, United States, 78229
Contact: Sandra Salas    210-617-4116 ext 1617    [e-mail]
Principal Investigator: Daniel Saltzstein, MD
United States, Virginia
Site 02-009 - Virginia Urology	Terminated
Richmond, Virginia, United States, 23235
United States, Wisconsin
Site 02-011 - University of Wisconsin Health University Hospital	Recruiting
Madison, Wisconsin, United States, 53792
Contact: Abigail Wiedmer    608-265-9172    [e-mail]
Principal Investigator: Dr. Kyle Richards, MD
Canada, British Columbia
Site 01-005 - The Vancouver Prostate Centre - Diamond Health Care Centre - Vancouver General Hospital	Recruiting
Vancouver, British Columbia, Canada, V5Z 1M9
Contact: Genevive Moreau    604-875-4111 ext 67898    [e-mail]
Principal Investigator: Peter Black, MD
Canada, Nova Scotia
Site 01-004 - Nova Scotia Health Authority - Centre for Applied Urology Research	Recruiting
Halifax, Nova Scotia, Canada, B3H 2Y9
Contact: Robin Simpson    902-473-7969    [e-mail]
Principal Investigator: Ricardo Rendon, M.D.
Canada, Ontario
Site 01-002- London Health Sciences Centre - Victoria Hospital	Recruiting
London, Ontario, Canada, N6A 5W9
Contact: Wendy Shoff    519-685-8500 ext 57350    [e-mail]
Principal Investigator: Jonathan Izawa, MD
Site 01-001 - University Health Network - Princess Margaret Cancer Centre	Recruiting
Toronto, Ontario, Canada, M5G 2C4
Contact: Sarah Cheung    437-335-2949    [e-mail]
Principal Investigator: Girish Kulkarni, MD
Canada, Quebec
Site 01-003 - McGill University Health Centre - Glen-Cedars Cancer Centre	Recruiting
Montral, Quebec, Canada, H4A 3J1
Contact: Rodrigo Skowronski    514-934-1934 ext 64222    [e-mail]
Principal Investigator: Wassim Kassouf, MD

Sponsors and Collaborators

https://clinicaltrials.gov/ct2/show/NCT03945162

[Rumpl3StiltSkin]

This info doesn't include the 9 new sites, bringing the total now to 20. If you look you'll see all these sites are recruiting. Except Virginia site, which was Terminated for some reason...??

[Oilminerdeluxe]

Any chance we might get a grant, like now?

[Infinity]

Rumpl,  Would you please elaborate on the new 9 sites that you are referring to? How does 12 + 9 new sites become 20?    I am missing something here.

[Rumpl3StiltSkin]

12-1 =11 The virginia site was Terminated. The 9 new sites have been announced in several recent NRs, last few years anyway. So I think 20 is the correct number.

[Infinity]

Rumpl,  I guess, I missed Virginia which is not recruiting.  Total of 11 are recruiting (or) in different phases of clinical study.  You mentioned all the 20 sites are recruiting now.  Do we know the names and locations of the new 9 clinical sites that was recently added and currently recruiting?

[CancerSlayer]

    Locations United States, Illinois Site 02-012 - University of Chicago Recruiting Chicago, Illinois, United States, 60637           United States, Pennsylvania Site

[Rumpl3StiltSkin]

Hmm, So are there going to be 9 new sites? Isn't that what the company has been touting for some time now? Maybe the new 9 aren't yet underway...??

[CancerSlayer]

  My guess is they get funding independently or via partnership before new sites are added?  Re: adding trial sites, they may also get more interest/cooperation from key medical centers post BTD.